James B. Breitmeyer, EVP, CMO at CADENCE PHARMACEUTICALS INC (CADX), sold 7,000 shares at $8.50 ($60K) on 2011-03-04, disclosed to the SEC on 2011-03-08.
Scheduled sale ($60k) by EVP, CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ZGNX | SELL | 2019-12-18 | $250K | — | Filing → |
| ZGNX | SELL | 2019-11-27 | $250K | — | Filing → |
| CADX | SELL | 2011-11-04 | $71K | — | Filing → |